• Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

  • Apr 25 2023
  • Durée : 26 min
  • Podcast

Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

  • Résumé

  • Rod S Passman, MD is interviewed by Happitech CEO and Founder Yosef Safi Harb

    Rod S Passman, MD is Director, Center for Arrhythmia Research and Jules J. Reingold Professor of Electrophysiology, Professor of Medicine (Cardiology) and Preventative Medicine

    An innovator for patients in Atrial Fibrillation, Dr. Passman is a highly regarded cardiac electrophysiologist and is an internationally recognized leader in cardiac monitoring and stroke prevention.

    Dr. Passman pioneered the use of implantable cardiac monitors to search for atrial fibrillation in stroke patients, a strategy now part of standard practice around the world. His current research focuses on implantable and wearable heart monitors to guide the use of anticoagulants in patients with atrial fibrillation.

    In this wide-ranging interview Dr Passman describes some of the benefits for patients of the emergence of consumer-style devices for remote patient monitoring. Dr. Passman also calls for more small-scale research studies, in partnership with the manufacturers of these devices, to evidence their ability to improve patient outcomes and save healthcare costs to encourage reimbursement by Payers.

    Afficher plus Afficher moins
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    activate_samplebutton_t1

    Ce que les auditeurs disent de Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.